Envista Obtains FDA Clearance for Assisted Intelligence Mandibular Nerve Tracing

/PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") -- Envista announced today the 510(k) Food and Drug Administration (FDA) clearance of its...

Related Keywords

Envista ,Nobel Biocare ,Stephen Keller ,Amir Aghdaei ,Prnewswire Envista Holdings Corporation ,Envista Holdings Corporation ,Drug Administration ,Holdings Corporation ,Assisted Intelligence ,Envista Business System ,Dentistry ,Health Care Amp Hospitals ,Computer Amp Electronics ,Medical Equipment ,Medical Pharmaceuticals ,Fda Approval ,